Detalhe da pesquisa
1.
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial.
World J Urol
; 41(9): 2381-2388, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37480491
2.
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test.
BJU Int
; 129(3): 356-363, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33751774